100 related articles for article (PubMed ID: 16973920)
1. Development of a simple high-throughput screening protocol based on biosynthetic activity of Mycobacterium tuberculosis glutamine synthetase for the identification of novel Inhibitors.
Singh U; Sarkar D
J Biomol Screen; 2006 Dec; 11(8):1035-42. PubMed ID: 16973920
[TBL] [Abstract][Full Text] [Related]
2. Development of a simple assay protocol for high-throughput screening of Mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors.
Singh U; Panchanadikar V; Sarkar D
J Biomol Screen; 2005 Oct; 10(7):725-9. PubMed ID: 16129778
[TBL] [Abstract][Full Text] [Related]
3. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
[TBL] [Abstract][Full Text] [Related]
4. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
Odell LR; Nilsson MT; Gising J; Lagerlund O; Muthas D; Nordqvist A; Karlén A; Larhed M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4790-3. PubMed ID: 19560924
[TBL] [Abstract][Full Text] [Related]
5. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors.
Nilsson MT; Krajewski WW; Yellagunda S; Prabhumurthy S; Chamarahally GN; Siddamadappa C; Srinivasa BR; Yahiaoui S; Larhed M; Karlén A; Jones TA; Mowbray SL
J Mol Biol; 2009 Oct; 393(2):504-13. PubMed ID: 19695264
[TBL] [Abstract][Full Text] [Related]
7. A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents.
Singh U; Akhtar S; Mishra A; Sarkar D
J Microbiol Methods; 2011 Feb; 84(2):202-7. PubMed ID: 21129420
[TBL] [Abstract][Full Text] [Related]
8. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
[TBL] [Abstract][Full Text] [Related]
9. A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli.
Khan A; Sarkar D
J Microbiol Methods; 2008 Apr; 73(1):62-8. PubMed ID: 18328582
[TBL] [Abstract][Full Text] [Related]
10. The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis: development of a novel assay and quantification of glycolipid-status of the mycobacterial cell wall.
Elamin AA; Stehr M; Oehlmann W; Singh M
J Microbiol Methods; 2009 Dec; 79(3):358-63. PubMed ID: 19857528
[TBL] [Abstract][Full Text] [Related]
11. Homogeneous and nonradioactive high-throughput screening platform for the characterization of kinase inhibitors in cell lysates.
Guenat S; Rouleau N; Bielmann C; Bedard J; Maurer F; Allaman-Pillet N; Nicod P; Bielefeld-Sévigny M; Beckmann JS; Bonny C; Bossé R; Roduit R
J Biomol Screen; 2006 Dec; 11(8):1015-26. PubMed ID: 17092917
[TBL] [Abstract][Full Text] [Related]
12. Screening, identification, and characterization of mechanistically diverse inhibitors of the Mycobacterium tuberculosis enzyme, pantothenate kinase (CoaA).
Venkatraman J; Bhat J; Solapure SM; Sandesh J; Sarkar D; Aishwarya S; Mukherjee K; Datta S; Malolanarasimhan K; Bandodkar B; Das KS
J Biomol Screen; 2012 Mar; 17(3):293-302. PubMed ID: 22086722
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonic acids as effective inhibitors of Mycobacterium tuberculosis glutamine synthetase.
Kosikowska P; Bochno M; Macegoniuk K; Forlani G; Kafarski P; Berlicki Ł
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):931-8. PubMed ID: 26235917
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
15. Nanomolar inhibitors of Mycobacterium tuberculosis glutamine synthetase 1: synthesis, biological evaluation and X-ray crystallographic studies.
Couturier C; Silve S; Morales R; Pessegue B; Llopart S; Nair A; Bauer A; Scheiper B; Pöverlein C; Ganzhorn A; Lagrange S; Bacqué E
Bioorg Med Chem Lett; 2015 Apr; 25(7):1455-9. PubMed ID: 25770781
[TBL] [Abstract][Full Text] [Related]
16. Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening.
Gutierrez-Lugo MT; Baker H; Shiloach J; Boshoff H; Bewley CA
J Biomol Screen; 2009 Jul; 14(6):643-52. PubMed ID: 19525487
[TBL] [Abstract][Full Text] [Related]
17. [High throughput screening for glutathione S-transferase inhibitors].
Zhang DS; Zhang TT; Li SJ; Du GH
Yao Xue Xue Bao; 2008 Jan; 43(1):108-12. PubMed ID: 18357743
[TBL] [Abstract][Full Text] [Related]
18. Development of an LC-MS based enzyme activity assay for MurC: application to evaluation of inhibitors and kinetic analysis.
Deng G; Gu RF; Marmor S; Fisher SL; Jahic H; Sanyal G
J Pharm Biomed Anal; 2004 Jun; 35(4):817-28. PubMed ID: 15193726
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glutamine synthetase during ammonia exposure in rainbow trout indicates a high reserve capacity to prevent brain ammonia toxicity.
Sanderson LA; Wright PA; Robinson JW; Ballantyne JS; Bernier NJ
J Exp Biol; 2010 Jul; 213(Pt 13):2343-53. PubMed ID: 20543133
[TBL] [Abstract][Full Text] [Related]
20. Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.
Dixon SM; Li P; Liu R; Wolosker H; Lam KS; Kurth MJ; Toney MD
J Med Chem; 2006 Apr; 49(8):2388-97. PubMed ID: 16610782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
